Eurofins Cerep SA (Cerep), a subsidiary of Eurofins Discovery Services LUX Holding SARL, is a drug discovery company which undertakes the pre-clinical research, discovery and development of new pharmaceutical drugs and focuses on offering in vitro and in vivo solutions. The solutions allow early discovery of promising drug candidates and terminating compounds likely to fail in development. The company's research services comprise compound management, high-throughput screening, in vitro safety profiling, lead optimization profiling, and in vivo pharmacokinetics. It also offers assay development, profile design and data interpretation services. It also operates laboratories in France, China and the US. Cerep is headquartered in Celle The Evescault, Poitou-Charentes, France.
Eurofins Cerep SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 220.127.116.11) - Pipeline Review, H2 2018 Summary Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 18.104.22.168) pipeline Target constitutes close to 25 molecules. Out of which approximately 24 molecules are developed by companies...
Peritonitis - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Peritonitis - Pipeline Review, H2 2018, provides an overview of the Peritonitis (Gastrointestinal) pipeline landscape. Peritonitis is inflammation of the peritoneum....
High Affinity Nerve Growth Factor Receptor (Neurotrophic Tyrosine Kinase Receptor Type 1 or TRK1 Transforming Tyrosine Kinase Protein or Tropomyosin Related Kinase A or Tyrosine Kinase Receptor or gp140trk or p140 TrkA or NTRK1 or EC 22.214.171.124) - Pipeline Review, H2 2018 Summary High Affinity Nerve...
Serine Protein Kinase ATM (Ataxia Telangiectasia Mutated or ATM or EC 126.96.36.199) - Pipeline Review, H2 2018 Summary Serine Protein Kinase ATM (Ataxia Telangiectasia Mutated or ATM or EC 188.8.131.52) pipeline Target constitutes close to 7 molecules. Out of which approximately 6 molecules are developed...
Obesity: Competitive Landscape to 2026 Summary Obesity is a preventable chronic condition, defined as abnormal or excessive fat accumulation characterized by raised body mass index (BMI ?30), which is a major risk factor for chronic diseases such as cardiovascular diseases (CVD), diabetes, musculoskeletal...